These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1599606)

  • 1. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.
    Buchsbaum MS; Potkin SG; Marshall JF; Lottenberg S; Teng C; Heh CW; Tafalla R; Reynolds C; Abel L; Plon L
    Neuropsychopharmacology; 1992 May; 6(3):155-63. PubMed ID: 1599606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration.
    Volkow ND; Brodie JD; Wolf AP; Angrist B; Russell J; Cancro R
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1199-1202. PubMed ID: 3491182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
    Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D
    Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.
    Bartlett EJ; Wolkin A; Brodie JD; Laska EM; Wolf AP; Sanfilipo M
    Psychiatry Res; 1991 Oct; 40(2):115-24. PubMed ID: 1763142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine effects on glucose metabolic rate in striatum and frontal cortex.
    Potkin SG; Buchsbaum MS; Jin Y; Tang C; Telford J; Friedman G; Lottenberg S; Najafi A; Gulasekaram B; Costa J
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():63-6. PubMed ID: 7961576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
    Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
    Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of metabolic activity in the treatment of schizophrenia.
    Brodie JD; Christman DR; Corona JF; Fowler JS; Gomez-Mont F; Jaeger J; Micheels PA; Rotrosen J; Russell JA; Volkow ND
    Ann Neurol; 1984; 15 Suppl():S166-9. PubMed ID: 6611117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients.
    Farde L; Nordström AL
    Br J Psychiatry Suppl; 1992 May; (17):30-3. PubMed ID: 1358126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response.
    Ertugrul A; Volkan-Salanci B; Basar K; Karli Oguz K; Demir B; Ergun EL; Senturk S; Erbas B; Cila A; Ulug B
    Psychiatry Res; 2009 Nov; 174(2):121-9. PubMed ID: 19837567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement.
    Molina V; Gispert JD; Reig S; Sanz J; Pascau J; Santos A; Desco M; Palomo T
    Psychopharmacology (Berl); 2005 Feb; 178(1):17-26. PubMed ID: 15365682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effect.
    Cohen RM; Nordahl TE; Semple WE; Pickar D
    Neuropsychopharmacology; 1999 Nov; 21(5):632-40. PubMed ID: 10516959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients.
    Farde L; Nordström AL; Nyberg S; Halldin C; Sedvall G
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():67-9. PubMed ID: 7961577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia.
    Buchsbaum MS; Potkin SG; Siegel BV; Lohr J; Katz M; Gottschalk LA; Gulasekaram B; Marshall JF; Lottenberg S; Teng CY
    Arch Gen Psychiatry; 1992 Dec; 49(12):966-74. PubMed ID: 1449383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central muscarinic acetylcholine receptor availability in patients treated with clozapine.
    Raedler TJ; Knable MB; Jones DW; Urbina RA; Egan MF; Weinberger DR
    Neuropsychopharmacology; 2003 Aug; 28(8):1531-7. PubMed ID: 12799613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia.
    Molina V; Reig S; Sarramea F; Sanz J; Francisco Artaloytia J; Luque R; Aragüés M; Pascau J; Benito C; Palomo T; Desco M
    Psychiatry Res; 2003 Nov; 124(3):153-61. PubMed ID: 14623067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine.
    Kapur S; Roy P; Daskalakis J; Remington G; Zipursky R
    Am J Psychiatry; 2001 Feb; 158(2):311-4. PubMed ID: 11156818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine.
    Potkin SG; Basile VS; Jin Y; Masellis M; Badri F; Keator D; Wu JC; Alva G; Carreon DT; Bunney WE; Fallon JH; Kennedy JL
    Mol Psychiatry; 2003 Jan; 8(1):109-13. PubMed ID: 12556915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.